Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients
Publié dansStrahlentherapie und Onkologie, vol. 194, no. 3, p. 215-224
Date de publication2018
Résumé
Mots-clés
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
- Brain Neoplasms/pathology/therapy
- Chemoradiotherapy/adverse effects/methods
- Child
- Child
- Preschool
- Cisplatin/administration & dosage/adverse effects
- Cohort Studies
- Dacarbazine/administration & dosage/adverse effects/analogs & derivatives
- Etoposide/administration & dosage/adverse effects
- Female
- Glioma/pathology/therapy
- Humans
- Ifosfamide/administration & dosage/adverse effects
- Leukopenia/chemically induced
- Male
- Neoplasm Grading
- Prospective Studies
- Temozolomide
- Treatment Outcome
- Vincristine/administration & dosage/adverse effects
- Drug toxicity
- Leukopenia
- Pediatric malignant glioma
- Platinum-based radiochemotherapy
- Temozolomide
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
SEIDEL, Clemens et al. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients. In: Strahlentherapie und Onkologie, 2018, vol. 194, n° 3, p. 215–224. doi: 10.1007/s00066-017-1218-6
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:128588
- DOI : 10.1007/s00066-017-1218-6
- PMID : 29022050
ISSN du journal0179-7158
